Kezar Life Sciences IncNASDAQ:KZRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7699
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.7406/ 12
- Ask / Lots0.7980/ 1
- Open / Previous Close0.0000 / 0.7699
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KZR |
|---|---|---|
| 09:32 ET | 4282 | 0.7744 |
| 09:34 ET | 2705 | 0.77 |
| 09:36 ET | 2035 | 0.77 |
| 09:39 ET | 700 | 0.7702 |
| 09:41 ET | 3139 | 0.7703 |
| 09:43 ET | 1300 | 0.77025 |
| 09:45 ET | 16917 | 0.7603 |
| 09:48 ET | 300 | 0.7603 |
| 09:50 ET | 200 | 0.765 |
| 09:52 ET | 4678 | 0.7507 |
| 09:56 ET | 20000 | 0.7532 |
| 09:57 ET | 31779 | 0.7416 |
| 09:59 ET | 800 | 0.7424 |
| 10:01 ET | 22033 | 0.7482 |
| 10:03 ET | 100 | 0.7491 |
| 10:06 ET | 10695 | 0.7498 |
| 10:08 ET | 3828 | 0.7505 |
| 10:10 ET | 3599 | 0.7504 |
| 10:12 ET | 15972 | 0.7506 |
| 10:15 ET | 10445 | 0.7504 |
| 10:17 ET | 15653 | 0.7506 |
| 10:19 ET | 1100 | 0.7507 |
| 10:21 ET | 1900 | 0.7599 |
| 10:26 ET | 200 | 0.7553 |
| 10:28 ET | 700 | 0.7599 |
| 10:30 ET | 300 | 0.759 |
| 10:32 ET | 200 | 0.759 |
| 10:33 ET | 1100 | 0.759 |
| 10:37 ET | 100 | 0.7576 |
| 10:39 ET | 200 | 0.7576 |
| 10:42 ET | 200 | 0.75936 |
| 10:44 ET | 2700 | 0.7577 |
| 10:46 ET | 300 | 0.75904 |
| 10:48 ET | 662 | 0.7578 |
| 10:50 ET | 200 | 0.7578 |
| 10:51 ET | 300 | 0.7599 |
| 10:53 ET | 200 | 0.76 |
| 10:55 ET | 3300 | 0.76 |
| 11:00 ET | 200 | 0.76 |
| 11:02 ET | 6662 | 0.7569 |
| 11:06 ET | 6535 | 0.7564 |
| 11:09 ET | 2635 | 0.7563 |
| 11:15 ET | 200 | 0.756 |
| 11:18 ET | 300 | 0.756 |
| 11:20 ET | 500 | 0.7553 |
| 11:22 ET | 400 | 0.756 |
| 11:24 ET | 100 | 0.756 |
| 11:26 ET | 300 | 0.756 |
| 11:27 ET | 602 | 0.7553 |
| 11:29 ET | 1190 | 0.7536 |
| 11:31 ET | 100 | 0.7536 |
| 11:36 ET | 100 | 0.7506 |
| 11:38 ET | 200 | 0.7506 |
| 11:40 ET | 1100 | 0.7541 |
| 11:42 ET | 18502 | 0.7486 |
| 11:44 ET | 2230 | 0.75025 |
| 11:45 ET | 10514 | 0.75 |
| 11:47 ET | 131 | 0.74865 |
| 11:51 ET | 13750 | 0.7673 |
| 11:54 ET | 31580 | 0.76 |
| 11:58 ET | 400 | 0.7601 |
| 12:00 ET | 100 | 0.7601 |
| 12:02 ET | 100 | 0.768 |
| 12:03 ET | 100 | 0.768 |
| 12:05 ET | 1400 | 0.76405 |
| 12:07 ET | 100 | 0.76405 |
| 12:09 ET | 200 | 0.760401 |
| 12:14 ET | 100 | 0.768 |
| 12:16 ET | 2251 | 0.768 |
| 12:18 ET | 443 | 0.768 |
| 12:21 ET | 300 | 0.768 |
| 12:23 ET | 200 | 0.7607 |
| 12:25 ET | 1100 | 0.76435 |
| 12:30 ET | 600 | 0.7607 |
| 12:32 ET | 100 | 0.7607 |
| 12:34 ET | 100 | 0.76435 |
| 12:36 ET | 1100 | 0.7607 |
| 12:38 ET | 818 | 0.7621 |
| 12:39 ET | 2200 | 0.7668 |
| 12:41 ET | 200 | 0.763 |
| 12:43 ET | 10600 | 0.76 |
| 12:48 ET | 1017 | 0.7619 |
| 12:50 ET | 300 | 0.7601 |
| 12:52 ET | 1000 | 0.7607 |
| 12:54 ET | 200 | 0.7607 |
| 12:56 ET | 12467 | 0.7609 |
| 12:57 ET | 100 | 0.7602 |
| 12:59 ET | 100 | 0.7602 |
| 01:06 ET | 15500 | 0.76155 |
| 01:08 ET | 700 | 0.76155 |
| 01:10 ET | 600 | 0.7616 |
| 01:12 ET | 700 | 0.76155 |
| 01:14 ET | 500 | 0.7615 |
| 01:15 ET | 698 | 0.7615 |
| 01:17 ET | 600 | 0.7615 |
| 01:19 ET | 300 | 0.7615 |
| 01:21 ET | 200 | 0.7615 |
| 01:24 ET | 1608 | 0.7651 |
| 01:26 ET | 200 | 0.7635 |
| 01:32 ET | 300 | 0.76575 |
| 01:33 ET | 1400 | 0.768 |
| 01:35 ET | 4900 | 0.7617 |
| 01:37 ET | 200 | 0.7612 |
| 01:39 ET | 200 | 0.7612 |
| 01:44 ET | 400 | 0.7612 |
| 01:46 ET | 100 | 0.7612 |
| 01:48 ET | 1286 | 0.7612 |
| 01:50 ET | 42459 | 0.7672 |
| 01:51 ET | 400 | 0.7658 |
| 01:53 ET | 200 | 0.7658 |
| 01:55 ET | 100 | 0.7635 |
| 02:00 ET | 100 | 0.7635 |
| 02:02 ET | 600 | 0.768 |
| 02:04 ET | 1335 | 0.768 |
| 02:06 ET | 400 | 0.7665 |
| 02:08 ET | 200 | 0.768 |
| 02:09 ET | 300 | 0.768 |
| 02:11 ET | 1300 | 0.768 |
| 02:13 ET | 100 | 0.768 |
| 02:15 ET | 495 | 0.7673 |
| 02:18 ET | 100 | 0.768 |
| 02:20 ET | 100 | 0.768 |
| 02:22 ET | 1000 | 0.768 |
| 02:24 ET | 800 | 0.7676 |
| 02:26 ET | 882 | 0.7677 |
| 02:27 ET | 200 | 0.7677 |
| 02:29 ET | 300 | 0.7677 |
| 02:31 ET | 100 | 0.7677 |
| 02:33 ET | 3082 | 0.768 |
| 02:36 ET | 300 | 0.76795 |
| 02:38 ET | 650 | 0.767948 |
| 02:40 ET | 200 | 0.768 |
| 02:42 ET | 500 | 0.768 |
| 02:44 ET | 1300 | 0.76795 |
| 02:45 ET | 2200 | 0.7679 |
| 02:47 ET | 1603 | 0.7679 |
| 02:49 ET | 1000 | 0.7679 |
| 02:51 ET | 400 | 0.7679 |
| 02:54 ET | 300 | 0.768 |
| 02:56 ET | 600 | 0.768 |
| 02:58 ET | 200 | 0.768 |
| 03:00 ET | 1484 | 0.7679 |
| 03:02 ET | 3530 | 0.768 |
| 03:03 ET | 200 | 0.768 |
| 03:05 ET | 2646 | 0.7683 |
| 03:07 ET | 8400 | 0.7684 |
| 03:12 ET | 300 | 0.7684 |
| 03:14 ET | 2138 | 0.7683 |
| 03:16 ET | 10384 | 0.7679 |
| 03:18 ET | 300 | 0.76795 |
| 03:20 ET | 3965 | 0.7658 |
| 03:21 ET | 300 | 0.7638 |
| 03:23 ET | 1717 | 0.76375 |
| 03:25 ET | 300 | 0.7637 |
| 03:27 ET | 100 | 0.7638 |
| 03:32 ET | 200 | 0.7638 |
| 03:34 ET | 200 | 0.7638 |
| 03:36 ET | 4585 | 0.7634 |
| 03:38 ET | 467 | 0.7601 |
| 03:39 ET | 3728 | 0.76 |
| 03:41 ET | 5100 | 0.76005 |
| 03:43 ET | 1227 | 0.76 |
| 03:45 ET | 100 | 0.76 |
| 03:48 ET | 362 | 0.76 |
| 03:50 ET | 3410 | 0.7601 |
| 03:52 ET | 406 | 0.76 |
| 03:54 ET | 300 | 0.7601 |
| 03:56 ET | 2941 | 0.76 |
| 03:57 ET | 4808 | 0.76 |
| 03:59 ET | 4967 | 0.7699 |
May 10, 2024
DJ Kezar Life Sciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co., from 8:06AM ET on Friday May 10, 2024 by Dow Jones
8:06AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones*DJ Kezar Life Sciences 1Q Loss/Shr 30c >KZR, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
May 6, 2024
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), from 4:05PM ET on Monday May 06, 2024 by Dow Jones
4:05PM ET on Monday May 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kezar Life Sciences Inc | 56.0M | -0.5x | --- |
Kronos Bio Inc | 62.5M | -0.5x | --- |
LAVA Therapeutics NV | 71.0M | -1.7x | --- |
BioLine RX Ltd | 51.5M | -0.7x | --- |
Jaguar Health Inc | 49.5M | -0.1x | --- |
Curis Inc | 62.0M | -1.2x | --- |
Company Information
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The Company's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). Its oncology product candidate, KZR-261, is a small molecule agent, targeting the Sec61 translocon and protein secretion pathway, being studied in an open-label Phase I clinical trial designed to evaluate safety and tolerability, pharmacokinetics and pharmacodynamics, as well to explore preliminary anti-tumor activity. This study is being conducted in two parts: dose escalation in patients with locally advanced or metastatic solid malignancies, and dose expansion in patients with selected tumor types.
Contact Information
- Headquarters
- 4000 Shoreline Ct Ste 300SOUTH SAN FRANCISCO, CA, United States 94080-2005
- Phone
- 650-822-5600
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Graham Cooper
- Chief Executive Officer, Director
- Christopher Kirk
- Chief Financial Officer, Secretary
- Marc Belsky
- Senior Vice President - Research and Drug Discovery
- Neel Anand
- Senior Vice President - CMC and Supply Chain
- Kieron Wesson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $56.0M |
|---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 72.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.24 |
EPS | $-1.40 |
Book Value | $2.58 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 8.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,591.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
